Metamfepramone is metabolized to produce N-methylpseudoephedrine and methcathinone.[4] It has also been found to be about 1.6 times less potent than methcathinone, making it roughly equipotent to cathinone itself.[5]
Legal Status
In the United States, metamfepramone (N,N-Dimethyl-cathinone) is considered a Schedule I controlled substance as a positional isomer of mephedrone.[6]
^Soholing WE (February 1982). "[Therapy of the orthostatic syndrome. Studies using dimepropion-HCI]". Fortschritte der Medizin (in German). 100 (7): 289–293. PMID7042502.
^Thevis M, Sigmund G, Thomas A, Gougoulidis V, Rodchenkov G, Schänzer W (2009). "Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry". European Journal of Mass Spectrometry. 15 (4): 507–515. doi:10.1255/ejms.1010. PMID19661559. S2CID41715902.
^Dal Cason TA, Young R, Glennon RA (December 1997). "Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs". Pharmacology, Biochemistry, and Behavior. 58 (4): 1109–1116. doi:10.1016/s0091-3057(97)00323-7. PMID9408221. S2CID9704972.